{"transactions":[{"id":4633213,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-10-03T00:13:27.000Z","date":"2026-09-30","kind":"exercise","planned":false,"acquired":false,"shares":1360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":1361,"derivative":{"underlying":"Common Stock","underlying_shares":1360},"source":{"system":"sec-edgar","filing":"0000905148-26-004336","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826004336/form4.xml","form_type":"4"}},{"id":4633212,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2026-10-03T00:13:27.000Z","date":"2026-09-30","kind":"exercise","planned":false,"acquired":true,"shares":1360,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."}],"balance_after":26743,"source":{"system":"sec-edgar","filing":"0000905148-26-004336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826004336/form4.xml","form_type":"4"}},{"id":688354,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Emeritus Director"}}],"security":"Common Stock","published_at":"2026-08-13T21:22:51.000Z","date":"2026-08-12","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":24.4661,"value":366991.5,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.00 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust."}],"balance_after":555810,"source":{"system":"sec-edgar","filing":"0000905148-26-003641","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021412/000090514826003641/form4.xml","form_type":"4"}},{"id":689795,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Emeritus Director"}}],"security":"Common Stock","published_at":"2026-08-12T21:55:16.000Z","date":"2026-08-11","kind":"purchase","planned":false,"acquired":true,"shares":13700,"price":24.0081,"value":328910.97,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.965 to $24.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust."}],"balance_after":540810,"source":{"system":"sec-edgar","filing":"0000905148-26-003599","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021412/000090514826003599/form4.xml","form_type":"4"}},{"id":689794,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Emeritus Director"}}],"security":"Common Stock","published_at":"2026-08-12T21:55:16.000Z","date":"2026-08-10","kind":"purchase","planned":false,"acquired":true,"shares":13900,"price":24.2467,"value":337029.13,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.89 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reported amounts have been adjusted to reflect (i) the transfer of 750,000 shares previously held by the Jack W. Schuler 2025 GRAT to the Jack W. Schuler Living Trust on March 25, 2026 and (ii) the transfer of 1,800,000 shares previously held by the Jack W. Schuler Living Trust to the Jack W. Schuler 2026 GRAT on April 1, 2026, each of which was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust."}],"balance_after":527110,"source":{"system":"sec-edgar","filing":"0000905148-26-003599","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021412/000090514826003599/form4.xml","form_type":"4"}},{"id":719241,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-07-02T20:27:45.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":false,"shares":1361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":2721,"derivative":{"underlying":"Common Stock","underlying_shares":1361},"source":{"system":"sec-edgar","filing":"0000905148-26-003146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826003146/form4.xml","form_type":"4"}},{"id":719240,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2026-07-02T20:27:45.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":true,"shares":1361,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."}],"balance_after":25383,"source":{"system":"sec-edgar","filing":"0000905148-26-003146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826003146/form4.xml","form_type":"4"}},{"id":821072,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-04-02T20:52:13.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":false,"shares":1361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":4082,"derivative":{"underlying":"Common Stock","underlying_shares":1361},"source":{"system":"sec-edgar","filing":"0000905148-26-001495","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826001495/form4.xml","form_type":"4"}},{"id":821071,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2026-04-02T20:52:13.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":1361,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."}],"balance_after":24022,"source":{"system":"sec-edgar","filing":"0000905148-26-001495","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826001495/form4.xml","form_type":"4"}},{"id":887959,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-24T01:22:26.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":1528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":4582,"derivative":{"underlying":"Common Stock","underlying_shares":1528},"source":{"system":"sec-edgar","filing":"0000905148-26-000987","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000987/form4.xml","form_type":"4"}},{"id":887958,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:22:26.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":556,"price":12.7756,"value":7103.2336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $12.58 to $13.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10359,"source":{"system":"sec-edgar","filing":"0000905148-26-000987","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000987/form4.xml","form_type":"4"}},{"id":887957,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:22:26.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":1528,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":10915,"source":{"system":"sec-edgar","filing":"0000905148-26-000987","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000987/form4.xml","form_type":"4"}},{"id":887956,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-24T01:22:24.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":1469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":4406,"derivative":{"underlying":"Common Stock","underlying_shares":1469},"source":{"system":"sec-edgar","filing":"0000905148-26-000986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000986/form4.xml","form_type":"4"}},{"id":887955,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:22:24.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":535,"price":12.7756,"value":6834.946,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $12.58 to $13.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9819,"source":{"system":"sec-edgar","filing":"0000905148-26-000986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000986/form4.xml","form_type":"4"}},{"id":887954,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:22:24.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":1469,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":10354,"source":{"system":"sec-edgar","filing":"0000905148-26-000986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000986/form4.xml","form_type":"4"}},{"id":887953,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-02-24T01:22:23.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":1469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":4406,"derivative":{"underlying":"Common Stock","underlying_shares":1469},"source":{"system":"sec-edgar","filing":"0000905148-26-000989","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000989/form4.xml","form_type":"4"}},{"id":887952,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-24T01:22:23.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":535,"price":12.7756,"value":6834.946,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $12.58 to $13.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16231,"source":{"system":"sec-edgar","filing":"0000905148-26-000989","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000989/form4.xml","form_type":"4"}},{"id":887951,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-24T01:22:23.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":1469,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":16766,"source":{"system":"sec-edgar","filing":"0000905148-26-000989","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000989/form4.xml","form_type":"4"}},{"id":887950,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-24T01:22:21.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":1689,"derivative":{"underlying":"Common Stock","underlying_shares":563},"source":{"system":"sec-edgar","filing":"0000905148-26-000990","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000990/form4.xml","form_type":"4"}},{"id":887949,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:22:21.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":211,"price":12.7756,"value":2695.6516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $12.58 to $13.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1586,"source":{"system":"sec-edgar","filing":"0000905148-26-000990","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000990/form4.xml","form_type":"4"}},{"id":887948,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:22:21.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":563,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":1797,"source":{"system":"sec-edgar","filing":"0000905148-26-000990","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000990/form4.xml","form_type":"4"}},{"id":888115,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-23T20:22:20.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":4844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":14531,"derivative":{"underlying":"Common Stock","underlying_shares":4844},"source":{"system":"sec-edgar","filing":"0000905148-26-000988","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514826000988/form4.xml","form_type":"4"}},{"id":888114,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-02-23T20:22:20.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":1490,"price":12.7756,"value":19035.644,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $12.58 to $13.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":48767,"source":{"system":"sec-edgar","filing":"0000905148-26-000988","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514826000988/form4.xml","form_type":"4"}},{"id":888113,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-02-23T20:22:20.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":4844,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":50257,"source":{"system":"sec-edgar","filing":"0000905148-26-000988","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514826000988/form4.xml","form_type":"4"}},{"id":909839,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T23:03:26.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":1527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":1526,"derivative":{"underlying":"Common Stock","underlying_shares":1527},"source":{"system":"sec-edgar","filing":"0000905148-26-000635","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000635/form4.xml","form_type":"4"}},{"id":909838,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T23:03:26.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":73,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":73},"source":{"system":"sec-edgar","filing":"0000905148-26-000635","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000635/form4.xml","form_type":"4"}},{"id":909837,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-11T23:03:26.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":584,"price":10.0841,"value":5889.1144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8885,"source":{"system":"sec-edgar","filing":"0000905148-26-000635","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000635/form4.xml","form_type":"4"}},{"id":909836,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-11T23:03:26.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":1600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":9469,"source":{"system":"sec-edgar","filing":"0000905148-26-000635","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000635/form4.xml","form_type":"4"}},{"id":909835,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T23:03:25.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":234,"derivative":{"underlying":"Common Stock","underlying_shares":235},"source":{"system":"sec-edgar","filing":"0000905148-26-000636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000636/form4.xml","form_type":"4"}},{"id":909834,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T23:03:25.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":28,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":28},"source":{"system":"sec-edgar","filing":"0000905148-26-000636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000636/form4.xml","form_type":"4"}},{"id":909833,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-11T23:03:25.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":101,"price":10.0841,"value":1018.4941,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1234,"source":{"system":"sec-edgar","filing":"0000905148-26-000636","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000636/form4.xml","form_type":"4"}},{"id":909832,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-11T23:03:25.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":263,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":1335,"source":{"system":"sec-edgar","filing":"0000905148-26-000636","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000636/form4.xml","form_type":"4"}},{"id":909831,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T23:03:21.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":2427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":2426,"derivative":{"underlying":"Common Stock","underlying_shares":2427},"source":{"system":"sec-edgar","filing":"0000905148-26-000637","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000637/form4.xml","form_type":"4"}},{"id":909830,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T23:03:21.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":157},"source":{"system":"sec-edgar","filing":"0000905148-26-000637","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000637/form4.xml","form_type":"4"}},{"id":909829,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-11T23:03:21.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":941,"price":10.0841,"value":9489.1381,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15297,"source":{"system":"sec-edgar","filing":"0000905148-26-000637","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000637/form4.xml","form_type":"4"}},{"id":909828,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-11T23:03:21.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":2584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":16238,"source":{"system":"sec-edgar","filing":"0000905148-26-000637","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000637/form4.xml","form_type":"4"}},{"id":909827,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T23:03:20.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":1413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":1412,"derivative":{"underlying":"Common Stock","underlying_shares":1413},"source":{"system":"sec-edgar","filing":"0000905148-26-000634","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000634/form4.xml","form_type":"4"}},{"id":909826,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T23:03:20.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":68,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":68},"source":{"system":"sec-edgar","filing":"0000905148-26-000634","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000634/form4.xml","form_type":"4"}},{"id":909825,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-11T23:03:20.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":540,"price":10.0841,"value":5445.414,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9387,"source":{"system":"sec-edgar","filing":"0000905148-26-000634","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000634/form4.xml","form_type":"4"}},{"id":909824,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-11T23:03:20.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":1481,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":9927,"source":{"system":"sec-edgar","filing":"0000905148-26-000634","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000634/form4.xml","form_type":"4"}},{"id":909975,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T18:03:23.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":9388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":9388,"derivative":{"underlying":"Common Stock","underlying_shares":9388},"source":{"system":"sec-edgar","filing":"0000905148-26-000633","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514826000633/form4.xml","form_type":"4"}},{"id":909974,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T18:03:23.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":610},"source":{"system":"sec-edgar","filing":"0000905148-26-000633","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514826000633/form4.xml","form_type":"4"}},{"id":909973,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-02-11T18:03:23.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":3559,"price":10.0841,"value":35889.3119,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":45413,"source":{"system":"sec-edgar","filing":"0000905148-26-000633","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514826000633/form4.xml","form_type":"4"}},{"id":909972,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-02-11T18:03:23.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":9998,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":48972,"source":{"system":"sec-edgar","filing":"0000905148-26-000633","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514826000633/form4.xml","form_type":"4"}},{"id":930378,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Emeritus Director"}}],"security":"Common Stock","published_at":"2026-01-27T14:29:02.000Z","date":"2026-01-26","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":11.8032,"value":236064.0,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.56 to $11.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust."}],"balance_after":1563210,"source":{"system":"sec-edgar","filing":"0000905148-26-000362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021412/000090514826000362/form4.xml","form_type":"4"}},{"id":930377,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Emeritus Director"}}],"security":"Common Stock","published_at":"2026-01-27T14:29:02.000Z","date":"2026-01-23","kind":"purchase","planned":false,"acquired":true,"shares":80000,"price":11.8084,"value":944672.0,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.225 to $12.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust."}],"balance_after":1543210,"source":{"system":"sec-edgar","filing":"0000905148-26-000362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021412/000090514826000362/form4.xml","form_type":"4"}},{"id":931392,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Emeritus Director"}}],"security":"Common Stock","published_at":"2026-01-26T14:28:57.000Z","date":"2026-01-22","kind":"purchase","planned":false,"acquired":true,"shares":82465,"price":10.9569,"value":903560.7585,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.675 to $11.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust."}],"balance_after":1463210,"source":{"system":"sec-edgar","filing":"0000905148-26-000331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021412/000090514826000331/form4.xml","form_type":"4"}},{"id":935318,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T21:22:18.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":false,"shares":219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":436,"derivative":{"underlying":"Common Stock","underlying_shares":219},"source":{"system":"sec-edgar","filing":"0000905148-26-000253","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000253/form4.xml","form_type":"4"}},{"id":935317,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:22:18.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":83,"price":8.1493,"value":676.3919,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $8.10 to $8.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1072,"source":{"system":"sec-edgar","filing":"0000905148-26-000253","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000253/form4.xml","form_type":"4"}},{"id":935316,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:22:18.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":true,"shares":219,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":1155,"source":{"system":"sec-edgar","filing":"0000905148-26-000253","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000253/form4.xml","form_type":"4"}},{"id":935327,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T21:21:56.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":false,"shares":805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":1609,"derivative":{"underlying":"Common Stock","underlying_shares":805},"source":{"system":"sec-edgar","filing":"0000905148-26-000252","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000252/form4.xml","form_type":"4"}},{"id":935326,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:21:56.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":298,"price":8.1493,"value":2428.4914,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $8.10 to $8.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8446,"source":{"system":"sec-edgar","filing":"0000905148-26-000252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000252/form4.xml","form_type":"4"}},{"id":935325,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:21:56.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":true,"shares":805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":8744,"source":{"system":"sec-edgar","filing":"0000905148-26-000252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000252/form4.xml","form_type":"4"}},{"id":935312,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T21:21:44.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":false,"shares":805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":1609,"derivative":{"underlying":"Common Stock","underlying_shares":805},"source":{"system":"sec-edgar","filing":"0000905148-26-000251","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000251/form4.xml","form_type":"4"}},{"id":935311,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:21:44.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":298,"price":8.1493,"value":2428.4914,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $8.10 to $8.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7869,"source":{"system":"sec-edgar","filing":"0000905148-26-000251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000251/form4.xml","form_type":"4"}},{"id":935310,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:21:44.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":true,"shares":805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":8167,"source":{"system":"sec-edgar","filing":"0000905148-26-000251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000251/form4.xml","form_type":"4"}},{"id":935309,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"officer":true,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T21:21:07.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":false,"shares":805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":1609,"derivative":{"underlying":"Common Stock","underlying_shares":805},"source":{"system":"sec-edgar","filing":"0000905148-26-000249","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000249/form4.xml","form_type":"4"}},{"id":935308,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"officer":true,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Common Stock","published_at":"2026-01-20T21:21:07.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":298,"price":8.1493,"value":2428.4914,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $8.10 to $8.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13654,"source":{"system":"sec-edgar","filing":"0000905148-26-000249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000249/form4.xml","form_type":"4"}},{"id":935307,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"officer":true,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Common Stock","published_at":"2026-01-20T21:21:07.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":true,"shares":805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":13952,"source":{"system":"sec-edgar","filing":"0000905148-26-000249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000249/form4.xml","form_type":"4"}},{"id":935406,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T16:21:20.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":false,"shares":2633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":5265,"derivative":{"underlying":"Common Stock","underlying_shares":2633},"source":{"system":"sec-edgar","filing":"0000905148-26-000250","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514826000250/form4.xml","form_type":"4"}},{"id":935405,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-20T16:21:20.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":970,"price":8.1493,"value":7904.821,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $8.10 to $8.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":38974,"source":{"system":"sec-edgar","filing":"0000905148-26-000250","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514826000250/form4.xml","form_type":"4"}},{"id":935404,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-20T16:21:20.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":true,"shares":2633,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":39944,"source":{"system":"sec-edgar","filing":"0000905148-26-000250","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514826000250/form4.xml","form_type":"4"}},{"id":946309,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:27:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000074","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000074/form4.xml","form_type":"4"}},{"id":946308,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:27:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":8164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":8164,"derivative":{"underlying":"Common Stock","underlying_shares":8164},"source":{"system":"sec-edgar","filing":"0000905148-26-000074","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000074/form4.xml","form_type":"4"}},{"id":946306,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:27:01.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000073/form4.xml","form_type":"4"}},{"id":946305,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:27:01.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":6804,"derivative":{"underlying":"Common Stock","underlying_shares":6804},"source":{"system":"sec-edgar","filing":"0000905148-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000073/form4.xml","form_type":"4"}},{"id":948237,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:26:46.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":1143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vested in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vested in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1143},"source":{"system":"sec-edgar","filing":"0000905148-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826000072/form4.xml","form_type":"4"}},{"id":948236,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:26:46.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826000072/form4.xml","form_type":"4"}},{"id":948235,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:26:46.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":5443,"derivative":{"underlying":"Common Stock","underlying_shares":5443},"source":{"system":"sec-edgar","filing":"0000905148-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826000072/form4.xml","form_type":"4"}},{"id":948234,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2026-01-06T21:26:46.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":1143,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."}],"balance_after":22661,"source":{"system":"sec-edgar","filing":"0000905148-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514826000072/form4.xml","form_type":"4"}},{"id":946304,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:26:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000070/form4.xml","form_type":"4"}},{"id":946303,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":69980,"kind":"person","name":"Kennedy Lawrence T. Jr","position":1,"cik":"0001830773","reported_name":"Kennedy Lawrence T. Jr","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:26:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":5443,"derivative":{"underlying":"Common Stock","underlying_shares":5443},"source":{"system":"sec-edgar","filing":"0000905148-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000070/form4.xml","form_type":"4"}},{"id":946302,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:25:57.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000069","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000069/form4.xml","form_type":"4"}},{"id":946301,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":41263,"kind":"person","name":"Kayyem Jon Faiz","position":1,"cik":"0001366268","reported_name":"Kayyem Jon Faiz","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:25:57.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":5443,"derivative":{"underlying":"Common Stock","underlying_shares":5443},"source":{"system":"sec-edgar","filing":"0000905148-26-000069","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000069/form4.xml","form_type":"4"}},{"id":946299,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:25:36.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of forty-eight successive, substantially equal monthly installments measured from January 2, 2026, generally subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":26000,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0000905148-26-000068","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000068/form4.xml","form_type":"4"}},{"id":946300,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:25:20.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of forty-eight successive, substantially equal monthly installments measured from January 2, 2026, generally subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":27000,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0000905148-26-000067","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000067/form4.xml","form_type":"4"}},{"id":946298,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"officer":true,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:24:53.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of forty-eight successive, substantially equal monthly installments measured from January 2, 2026, generally subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":29000,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0000905148-26-000065","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000065/form4.xml","form_type":"4"}},{"id":946297,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:24:41.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of forty-eight successive equal monthly installments measured from January 2, 2026, generally subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":12000,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000905148-26-000064","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000064/form4.xml","form_type":"4"}},{"id":947572,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T16:26:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514826000071/form4.xml","form_type":"4"}},{"id":947571,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-01-06T16:26:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":7484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":7484,"derivative":{"underlying":"Common Stock","underlying_shares":7484},"source":{"system":"sec-edgar","filing":"0000905148-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514826000071/form4.xml","form_type":"4"}},{"id":946817,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T16:25:05.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":97000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of forty-eight successive, substantially equal monthly installments measured from January 2, 2026, generally subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":97000,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":97000},"source":{"system":"sec-edgar","filing":"0000905148-26-000066","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514826000066/form4.xml","form_type":"4"}},{"id":1000110,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-13T21:54:19.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":false,"shares":31,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":29,"derivative":{"underlying":"Common Stock","underlying_shares":31},"source":{"system":"sec-edgar","filing":"0000905148-25-003933","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003933/form4.xml","form_type":"4"}},{"id":1000109,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:54:19.000Z","date":"2025-11-10","kind":"sale","planned":false,"acquired":false,"shares":13,"price":7.62,"value":99.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."}],"balance_after":936,"source":{"system":"sec-edgar","filing":"0000905148-25-003933","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003933/form4.xml","form_type":"4"}},{"id":1000108,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65170,"kind":"person","name":"Vazquez Chris","position":1,"cik":"0001980594","reported_name":"Vazquez Chris","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:54:19.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":true,"shares":31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":949,"source":{"system":"sec-edgar","filing":"0000905148-25-003933","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003933/form4.xml","form_type":"4"}},{"id":1000106,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-13T21:54:07.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":false,"shares":69,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":68,"derivative":{"underlying":"Common Stock","underlying_shares":69},"source":{"system":"sec-edgar","filing":"0000905148-25-003932","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003932/form4.xml","form_type":"4"}},{"id":1000105,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:54:07.000Z","date":"2025-11-10","kind":"sale","planned":false,"acquired":false,"shares":23,"price":7.62,"value":175.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."}],"balance_after":7939,"source":{"system":"sec-edgar","filing":"0000905148-25-003932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003932/form4.xml","form_type":"4"}},{"id":1000104,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65173,"kind":"person","name":"Pestano Gary Anthony","position":1,"cik":"0001827711","reported_name":"Pestano Gary Anthony","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:54:07.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":true,"shares":69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":7962,"source":{"system":"sec-edgar","filing":"0000905148-25-003932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003932/form4.xml","form_type":"4"}},{"id":1000103,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-13T21:53:56.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":false,"shares":75,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."}],"balance_after":73,"derivative":{"underlying":"Common Stock","underlying_shares":75},"source":{"system":"sec-edgar","filing":"0000905148-25-003931","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003931/form4.xml","form_type":"4"}},{"id":1000102,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:53:56.000Z","date":"2025-11-10","kind":"sale","planned":false,"acquired":false,"shares":25,"price":7.62,"value":190.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."}],"balance_after":7362,"source":{"system":"sec-edgar","filing":"0000905148-25-003931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003931/form4.xml","form_type":"4"}},{"id":1000101,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:53:56.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":true,"shares":75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 309 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025."}],"balance_after":7387,"source":{"system":"sec-edgar","filing":"0000905148-25-003931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003931/form4.xml","form_type":"4"}},{"id":1000100,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"officer":true,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2025-11-13T21:53:31.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":false,"shares":158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."}],"balance_after":157,"derivative":{"underlying":"Common Stock","underlying_shares":158},"source":{"system":"sec-edgar","filing":"0000905148-25-003929","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003929/form4.xml","form_type":"4"}},{"id":1000099,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"officer":true,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Common Stock","published_at":"2025-11-13T21:53:31.000Z","date":"2025-11-10","kind":"sale","planned":false,"acquired":false,"shares":50,"price":7.62,"value":381.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."}],"balance_after":13147,"source":{"system":"sec-edgar","filing":"0000905148-25-003929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003929/form4.xml","form_type":"4"}},{"id":1000098,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65171,"kind":"person","name":"Cowie Robin Harper","position":1,"cik":"0001827690","reported_name":"Cowie Robin Harper","relationship":{"officer":true,"officer_title":"CFO, Sec'y & Treasurer"}}],"security":"Common Stock","published_at":"2025-11-13T21:53:31.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":true,"shares":158,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 500 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025."}],"balance_after":13197,"source":{"system":"sec-edgar","filing":"0000905148-25-003929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003929/form4.xml","form_type":"4"}},{"id":1000280,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-11-13T16:53:44.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":false,"shares":611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."}],"balance_after":610,"derivative":{"underlying":"Common Stock","underlying_shares":611},"source":{"system":"sec-edgar","filing":"0000905148-25-003930","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514825003930/form4.xml","form_type":"4"}},{"id":1000279,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-11-13T16:53:44.000Z","date":"2025-11-10","kind":"sale","planned":false,"acquired":false,"shares":189,"price":7.62,"value":1440.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."}],"balance_after":37311,"source":{"system":"sec-edgar","filing":"0000905148-25-003930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514825003930/form4.xml","form_type":"4"}},{"id":1000278,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65186,"kind":"person","name":"Hutton Scott","position":1,"cik":"0001697361","reported_name":"Hutton Scott","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-11-13T16:53:44.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":true,"shares":611,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 448 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0000905148-25-003930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697361/000090514825003930/form4.xml","form_type":"4"}},{"id":1028164,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2025-10-02T20:04:20.000Z","date":"2025-09-30","kind":"exercise","planned":false,"acquired":false,"shares":1144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":1143,"derivative":{"underlying":"Common Stock","underlying_shares":1144},"source":{"system":"sec-edgar","filing":"0000905148-25-003485","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514825003485/form4.xml","form_type":"4"}},{"id":1028163,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":33236,"kind":"person","name":"PATIENCE JOHN","position":1,"cik":"0001021413","reported_name":"PATIENCE JOHN","relationship":{"director":true,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2025-10-02T20:04:20.000Z","date":"2025-09-30","kind":"exercise","planned":false,"acquired":true,"shares":1144,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":21518,"source":{"system":"sec-edgar","filing":"0000905148-25-003485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021413/000090514825003485/form4.xml","form_type":"4"}},{"id":1033958,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-09-23T13:29:04.000Z","date":"2025-09-19","kind":"purchase","planned":false,"acquired":true,"shares":142045,"price":7.04,"value":999996.8,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust."}],"balance_after":1380745,"source":{"system":"sec-edgar","filing":"0000905148-25-003392","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021412/000090514825003392/form4.xml","form_type":"4"}},{"id":1035810,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-09-19T14:31:11.000Z","date":"2025-09-18","kind":"purchase","planned":false,"acquired":true,"shares":3056,"price":6.1695,"value":18853.992,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.125 to $6.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust."}],"balance_after":1238700,"source":{"system":"sec-edgar","filing":"0000905148-25-003371","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021412/000090514825003371/form4.xml","form_type":"4"}}],"next_cursor":"2025-09-19T14:31:11.000000Z,1035810"}